(Q40838456)

24 September 2017

title

Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I. (English)

1 reference

24 September 2017

0 references

mucopolysaccharidosis I

1 reference

Pan D

1

1 reference

24 September 2017

Aronovich E

series ordinal

2

1 reference

24 September 2017

McIvor RS

series ordinal

3

1 reference

24 September 2017

Whitley CB

series ordinal

4

1 reference

24 September 2017

publication date

1 November 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

7

1 reference

24 September 2017

issue

21

1 reference

24 September 2017

page(s)

1875-1883

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301298

24 September 2017

exact match

0 references

cites work

Human gene therapy--an immature genie, but certainly out of the bottle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Gene therapy--promise, pitfalls, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Measuring success in clinical gene therapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Integration of foreign DNA and its consequences in mammalian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Expression of human adenosine deaminase in murine hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

In vivo drug-selectable genes: a new concept in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Quantitative analysis of gene suppression in integrated retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Dicistronic transcription units for gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Improved gene expression by a modified bicistronic retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

"Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

The use of nonneuronal cells for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

In vivo selection of retrovirally transduced hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Gene therapy. Is the future here yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

7 January 2021

Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

7 January 2021

New concepts for the development and use of antifolates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

7 January 2021

Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

7 January 2021

A safe packaging line for gene transfer: separating viral genes on two different plasmids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301298

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301298

1 reference

Dimensions Publication ID

24 September 2017

1027725104

0 references

1 reference